Westat Printer Friendly Version in PDF Format (3 PDF pages)
Substance Use & Substance Use Disorders (SUD)
Reports
Displaying 71 - 80 of 127. 10 per page. Page 8.
Advanced SearchASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
ASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.
Public Listing Status of Data-Waivered Providers: Data Brief
Printer Friendly Version in PDF Format (3 PDF pages)
Primary and Behavioral Health Care Integration Program: Impacts on Health Care Utilization, Cost, and Quality
This report describes an extension of the RAND Corporation's evaluation of the Substance Abuse and Mental Health Services Administration's Primary and Behavioral Health Care Integration (PBHCI) grants program.
Best Practices and Barriers to Engaging People with Substance Use Disorders in Treatment
Substance use disorders (SUDs) represent a serious public health problem in the United States. Recent attention has focused most on opioid use, including heroin use and prescription opioid misuse, with the attendant high rates of opioid-related overdoses. Alcohol use disorders are more common than opioid use disorders and also represent a public health concern.
ASPE Issue Brief
Expanding Access to Family-Centered Medication-Assisted Treatment Issue Brief
Printer Friendly Version in PDF Format (5 PDF pages)
State Policy Levers for Expanding Family-Centered Medication-Assisted Treatment
Printer Friendly Version in PDF Format (55 PDF pages)
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Final Report
This project assessed changes in Opioid Use Disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market at two timepoints, 2006-2007 and 2014-2015, that mark the periods before and after implementation of the Mental Health Parity and Addiction Equity Act (MHPAEA), the Affordable Care Act, the introduction and expanded use of new opioid treatme
Use of Medication-Assisted Treatment for Opioid Use Disorders in Employer-Sponsored Health Insurance: Out-of-Pocket Costs
This project assessed changes in opioid use disorder (OUD) treatment utilization and expenditures in the employer-sponsored private health insurance market during 2007 and 2014.
Using Telehealth to Identify and Manage Mental Health and Substance Use Disorder Conditions in Rural Areas
Access to services, particularly behavioral health and substance use disorder (SUD) treatment services, is challenging in rural and other underserved areas.